Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3034245, 15 pages
https://doi.org/10.1155/2017/3034245
Review Article

Cardiovascular Mitochondrial Dysfunction Induced by Cocaine: Biomarkers and Possible Beneficial Effects of Modulators of Oxidative Stress

1Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, Rome, Italy
2Drug Addiction and Clinical Pharmacology Unit, University Hospital Umberto I, Sapienza University of Rome, Rome, Italy
3Department of Biochemical Sciences “Alessandro Rossi Fanelli”, Sapienza University of Rome, Rome, Italy
4Sussex Addiction Research and Intervention Centre (SARIC), School of Psychology, University of Sussex, Brighton BN1 9RH, UK

Correspondence should be addressed to Manuela Graziani; ti.1amorinu@inaizarg.aleunam

Received 1 December 2016; Revised 8 March 2017; Accepted 26 March 2017; Published 16 May 2017

Academic Editor: Daniela Giustarini

Copyright © 2017 Manuela Graziani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. L. Coleman, T. F. Ross, and J. L. Naughton, “Myocardial ischemia and infarction related to recreational cocaine use,” The Western Journal of Medicine, vol. 136, no. 5, pp. 444–446, 1982. View at Google Scholar
  2. R. Virmani, M. Robinowitz, J. E. Smialek, and D. F. Smyth, “Cardiovascular effects of cocaine: an autopsy study of 40 patients,” American Heart Journal, vol. 115, no. 5, pp. 1068–1076, 1988. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Lange, R. G. Cigarroa, C. W. Yancy Jr et al., “Cocaine-induced coronary-artery vasoconstriction,” The New England Journal of Medicine, vol. 321, no. 23, pp. 1557–1562, 1989. View at Publisher · View at Google Scholar
  4. S. Maraj, V. M. Figueredo, and D. Lynn Morris, “Cocaine and the heart,” Clinical Cardiology, vol. 33, no. 5, pp. 264–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. E. Weber, C. R. Chudnofsky, M. Boczar, E. W. Boyer, M. D. Wilkerson, and J. E. Hollander, “Cocaine-associated chest pain: how common is myocardial infarction?” Academic Emergency Medicine, vol. 7, no. 8, pp. 873–877, 2000. View at Publisher · View at Google Scholar
  6. R. Khan, S. Arshed, W. Jehangir, S. Sen, and A. Yousif, “Cocaine-induced delayed myocardial infarction complicated by apical thrombus,” Journal of Clinical Medicine Research, vol. 8, no. 1, pp. 59–61, 2016. View at Publisher · View at Google Scholar
  7. A. Sarkar, A. Pande, G. N. Chandra, and I. Ahmed, “Acute myocardial infarction in a young cocaine addict with normal coronaries: time to raise awareness among emergency physicians,” Indian Journal of Critical Care Medicine, vol. 17, no. 1, pp. 56–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Graziani, L. Antonilli, A. R. Togna, M. C. Grassi, A. Badiani, and L. Saso, “Cardiovascular and hepatic toxicity of cocaine: potential beneficial effects of modulators of oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2016, no. 33, p. 8408479, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Liaudet, B. Calderari, and P. Pacher, “Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity,” Heart Failure Reviews, vol. 19, no. 6, pp. 815–824, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. B. G. Schwartz, S. Rezkalla, and R. A. Kloner, “Cardiovascular effects of cocaine,” Circulation, vol. 122, no. 24, pp. 2558–2569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Cerretani, V. Fineschi, S. Bello, I. Riezzo, E. Turillazzi, and M. Neri, “Role of oxidative stress in cocaine-induced cardiotoxicity and cocaine-related death,” Current Medicinal Chemistry, vol. 19, no. 33, pp. 5619–5623, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. C. Andersson, J. Fauconnier, T. Yamada et al., “Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytes,” The Journal of Physiology, vol. 589, no. Pt 7, pp. 1791–1801, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Xiao, D. R. Pimentel, J. Wang, K. Singh, W. S. Colucci, and D. B. Sawyer, “Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes,” American Journal of Physiology. Cell Physiology, vol. 282, no. 4, pp. C926–C934, 2002. View at Publisher · View at Google Scholar
  14. V. M. Costa, R. Silva, L. M. Ferreira et al., “Oxidation process of adrenaline in freshly isolated rat cardiomyocytes: formation of adrenochrome, quinoproteins, and GSH adduct,” Chemical Research in Toxicology, vol. 20, no. 8, pp. 1183–1191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Neri, D. Cerretani, A. I. Fiaschi et al., “Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats,” Journal of Cellular and Molecular Medicine, vol. 11, no. 1, pp. 156–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Pei, Y. Yang, H. Zhao et al., “The role of mitochondrial functional proteins in ROS production in ischemic heart diseases,” Oxidative Medicine and Cellular Longevity, vol. 2016, p. 5470457, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. D. B. Zorov, C. R. Filburn, L. O. Klotz, J. L. Zweier, and S. J. Sollott, “Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes,” The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1001–1014, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. V. Varga, P. Ferdinandy, L. Liaudet, and P. Pacher, “Drug-induced mitochondrial dysfunction and cardiotoxicity,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 309, no. 9, pp. H1453–H1467, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Vergeade, P. Mulder, C. Vendeville, R. Ventura-Clapier, C. Thuillez, and C. Monteil, “Xanthine oxidase contributes to mitochondrial ROS generation in an experimental model of cocaine-induced diastolic dysfunction,” Journal of Cardiovascular Pharmacology, vol. 60, no. 6, pp. 538–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Vergeade, P. Mulder, C. Vendeville-Dehaudt et al., “Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: prevention by the targeted antioxidant MitoQ,” Free Radical Biology & Medicine, vol. 49, no. 5, pp. 748–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Yuan and D. Acosta Jr., “Cocaine-induced mitochondrial dysfunction in primary cultures of rat cardiomyocytes,” Toxicology, vol. 112, no. 1, pp. 1–10, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. R. L. Grant and D. Acosta Jr., “A digitized fluorescence imaging study on the effects of local anesthetics on cytosolic calcium and mitochondrial membrane potential in cultured rabbit corneal epithelial cells,” Toxicology and Applied Pharmacology, vol. 129, no. 1, pp. 23–35, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Leon-Velarde, L. Huicho, and C. Monge, “Effects of cocaine on oxygen consumption and mitochondrial respiration in normoxic and hypoxic mice,” Life Sciences, vol. 50, no. 3, pp. 213–218, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. B. G. Devi and A. W. Chan, “Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury,” Life Sciences, vol. 60, no. 11, pp. 849–855, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Mitchell, “Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism,” Nature, vol. 191, no. 4784, pp. 144–148, 1961. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Gottlieb and D. Bernstein, “Mitochondrial remodeling: rearranging, recycling, and reprogramming,” Cell Calcium, vol. 60, no. 2, pp. 88–101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. D. E. Green and A. Tzagoloff, “The mitochondrial electron transfer chain,” Archives of Biochemistry and Biophysics, vol. 116, no. 1, pp. 293–304, 1966. View at Google Scholar
  28. C. R. Hackenbrock, B. Chazotte, and S. S. Gupte, “The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport,” Journal of Bioenergetics and Biomembranes, vol. 18, no. 5, pp. 331–368, 1986. View at Publisher · View at Google Scholar · View at Scopus
  29. M. L. Genova and G. Lenaz, “Functional role of mitochondrial respiratory supercomplexes,” Biochimica et Biophysica Acta, vol. 1837, no. 4, pp. 427–443, 2014. View at Google Scholar
  30. M. E. Dalmonte, E. Forte, M. L. Genova, A. Giuffrè, P. Sarti, and G. Lenaz, “Control of respiration by cytochrome c oxidase in intact cells: role of the membrane potential,” The Journal of Biological Chemistry, vol. 284, no. 47, pp. 32331–32335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Lenaz and M. L. Genova, “Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject,” Antioxidants & Redox Signaling, vol. 12, no. 8, pp. 961–1008, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. J. R. Friedman and J. Nunnari, “Mitochondrial form and function,” Nature, vol. 505, no. 7483, pp. 335–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Yuan and D. Acosta Jr., “Effect of cocaine on mitochondrial electron transport chain evaluated in primary cultures of neonatal rat myocardial cells and in isolated mitochondrial preparations,” Drug and Chemical Toxicology, vol. 23, no. 2, pp. 339–348, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. R. J. Kaufman and J. D. Malhotra, “Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics,” Biochimica et Biophysica Acta, vol. 1843, no. 10, pp. 2233–2239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Brini, T. Calì, D. Ottolini, and E. Carafoli, “Neuronal calcium signaling: function and dysfunction,” Cellular and Molecular Life Sciences, vol. 71, no. 15, pp. 2787–2814, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. R. M. Case, D. Eisner, A. Gurney, O. Jones, S. Muallem, and A. Verkhratsky, “Evolution of calcium homeostasis: from birth of the first cell to an omnipresent signalling system,” Cell Calcium, vol. 42, no. 4-5, pp. 345–350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Pinton, C. Giorgi, R. Siviero, E. Zecchini, and R. Rizzuto, “Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis,” Oncogene, vol. 27, no. 50, pp. 6407–6418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Görlach, K. Bertram, S. Hudecova, and O. Krizanova, “Calcium and ROS: a mutual interplay,” Redox Biology, vol. 6, pp. 260–271, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. Berridge, M. D. Bootman, and H. L. Roderick, “Calcium signalling: dynamics, homeostasis and remodelling,” Nature Reviews. Molecular Cell Biology, vol. 4, no. 7, pp. 517–529, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Tang, Y. X. Luo, H. Z. Chen, and D. P. Liu, “Mitochondria, endothelial cell function, and vascular diseases,” Frontiers in Physiology, vol. 5, p. 175, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Patergnani, J. M. Suski, C. Agnoletto et al., “Calcium signaling around mitochondria associated membranes (MAMs),” Cell Communication and Signaling: CCS, vol. 9, no. 1, p. 19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Marchi, S. Patergnani, and P. Pinton, “The endoplasmic reticulum-mitochondria connection: one touch, multiple functions,” Biochimica et Biophysica Acta, vol. 1837, no. 4, pp. 461–469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Ahuja and S. Muallem, “The gatekeepers of mitochondrial calcium influx: MICU1 and MICU2,” EMBO Reports, vol. 15, no. 3, pp. 205-206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Krizaj and D. R. Copenhagen, “Compartmentalization of calcium extrusion mechanisms in the outer and inner segments of photoreceptors,” Neuron, vol. 21, no. 1, pp. 249–256, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. G. C. Brailoiu, E. Deliu, L. M. Console-Bram et al., “Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: critical role for sigma-1 receptors,” The Biochemical Journal, vol. 473, no. 1, pp. 1–5, 2016. View at Google Scholar
  46. J. A. Rosado, “Sigma-1 receptors: a new pathway for the modulation of store-operated calcium entry,” The Biochemical Journal, vol. 473, no. 3, pp. e9–e10, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. R. A. Smith and M. P. Murphy, “Animal and human studies with the mitochondria-targeted antioxidant MitoQ,” Annals of the new York Academy of Sciences, vol. 1201, no. 1, pp. 96–103, 2010. View at Google Scholar
  48. G. Szabadkai and M. R. Duchen, “Mitochondria: The hub of cellular Ca2+ signaling,” Physiology (Bethesda), vol. 23, no. 2, pp. 84–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Kruman, Q. Guo, and M. P. Mattson, “Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells,” Journal of Neuroscience Research, vol. 51, no. 3, pp. 293–308, 1998. View at Publisher · View at Google Scholar
  50. K. Lynch, G. Fernandez, A. Pappalardo, and J. J. Peluso, “Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating intracellular free calcium levels through a protein kinase Cdelta-dependent pathway,” Endocrinology, vol. 141, no. 11, pp. 4209–4217, 2000. View at Publisher · View at Google Scholar
  51. S. Orrenius, B. Zhivotovsky, and P. Nicotera, “Regulation of cell death: the calcium-apoptosis link,” Nature Reviews. Molecular Cell Biology, vol. 4, no. 7, pp. 552–565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Tombal, S. R. Denmeade, and J. T. Isaacs, “Assessment and validation of a microinjection method for kinetic analysis of [Ca2+]i in individual cells undergoing apoptosis,” Cell Calcium, vol. 25, no. 1, pp. 19–28, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. R. B. Badisa, S. F. Darling-Reed, and C. B. Goodman, “Cocaine induces alterations in mitochondrial membrane potential and dual cell cycle arrest in rat c6 astroglioma cells,” Neurochemical Research, vol. 35, no. 2, pp. 288–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Sarti, A. Giuffrè, M. C. Barone, E. Forte, D. Mastronicola, and M. Brunori, “Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell,” Free Radical Biology & Medicine, vol. 34, no. 5, pp. 509–520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Mastronicola, E. Arcuri, M. Arese et al., “Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells,” Cellular and Molecular Life Sciences, vol. 61, no. 23, pp. 2991–2997, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Arese, M. C. Magnifico, D. Mastronicola et al., “Nanomolar melatonin enhances nNOS expression and controls HaCaT-cells bioenergetics,” IUBMB Life, vol. 64, no. 3, pp. 251–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Sarti, E. Forte, A. Giuffre, D. Mastronicola, M. C. Magnifico, and M. Arese, “The chemical interplay between nitric oxide and mitochondrial cytochrome c oxidase: reactions, effectors and pathophysiology,” International Journal of Cell Biology, vol. 2012, p. 571067, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. G. C. Brown and A. Vilalta, “How microglia kill neurons,” Brain Research, vol. 1628, no. Pt B, pp. 288–297, 2015. View at Publisher · View at Google Scholar
  60. A. Galkin and S. Moncada, “S-nitrosation of mitochondrial complex I depends on its structural conformation,” The Journal of Biological Chemistry, vol. 282, no. 52, pp. 37448–37453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. D. J. Stuehr and C. F. Nathan, “Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells,” The Journal of Experimental Medicine, vol. 169, no. 5, pp. 1543–1555, 1989. View at Publisher · View at Google Scholar
  62. P. I. Ortinski, “Cocaine-induced changes in NMDA receptor signaling,” Molecular Neurobiology, vol. 50, no. 2, pp. 494–506, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Sarti, E. Lendaro, R. Ippoliti, A. Bellelli, P. A. Benedetti, and M. Brunori, “Modulation of mitochondrial respiration by nitric oxide: investigation by single cell fluorescence microscopy,” The FASEB Journal, vol. 13, no. 1, pp. 191–197, 1999. View at Google Scholar
  64. C. N. Hall and J. Garthwaite, “What is the real physiological NO concentration in vivo?” Nitric Oxide, vol. 21, no. 2, pp. 92–103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. O. Lundberg, E. Weitzberg, and M. T. Gladwin, “The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics,” Nature Reviews. Drug Discovery, vol. 7, no. 2, pp. 156–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Itzhak, “Modulation of the PCP/NMDA receptor complex and sigma binding sites by psychostimulants,” Neurotoxicology and Teratology, vol. 16, no. 4, pp. 363–368, 1994. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Itzhak, “Attenuation of cocaine kindling by 7-nitroindazole, an inhibitor of brain nitric oxide synthase,” Neuropharmacology, vol. 35, no. 8, pp. 1065–1073, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. M. A. Balda, K. L. Anderson, and Y. Itzhak, “Adolescent and adult responsiveness to the incentive value of cocaine reward in mice: role of neuronal nitric oxide synthase (nNOS) gene,” Neuropharmacology, vol. 51, no. 2, pp. 341–349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. F. J. Nasif, X. T. Hu, O. A. Ramirez, and M. F. Perez, “Inhibition of neuronal nitric oxide synthase prevents alterations in medial prefrontal cortex excitability induced by repeated cocaine administration,” Psychopharmacology, vol. 218, no. 2, pp. 323–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Liddie, M. A. Balda, and Y. Itzhak, “Nitric oxide (NO) signaling as a potential therapeutic modality against psychostimulants,” Current Pharmaceutical Design, vol. 19, no. 40, pp. 7092–7102, 2013. View at Publisher · View at Google Scholar
  71. A. Frustaci, M. A. Russo, E. Morgante et al., “Oxidative myocardial damage in human cocaine-related cardiomyopathy,” European Journal of Heart Failure, vol. 17, no. 3, pp. 283–290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. V. Vitcheva, R. Simeonova, M. Kondeva-Burdina, and M. Mitcheva, “Selective nitric oxide synthase inhibitor 7-nitroindazole protects against cocaine-induced oxidative stress in rat brain,” Oxidative Medicine and Cellular Longevity, vol. 2015, p. 157876, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Masini, D. Gallesi, F. Giovannini, T. Trenti, and D. Ceccarelli, “Membrane potential of hepatic mitochondria after acute cocaine administration in rats—the role of mitochondrial reduced glutathione,” Hepatology, vol. 25, no. 2, pp. 385–390, 1997. View at Publisher · View at Google Scholar
  74. N. D. Volkow, J. S. Fowler, A. P. Wolf et al., “Distribution and kinetics of carbon-11-cocaine in the human body measured with PET,” Journal of Nuclear Medicine, vol. 33, no. 4, pp. 521–525, 1992. View at Google Scholar
  75. M. Portugal-Cohen, R. Numa, R. Yaka, and R. Kohen, “Cocaine induces oxidative damage to skin via xanthine oxidase and nitric oxide synthase,” Journal of Dermatological Science, vol. 58, no. 2, pp. 105–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Kovacic, “Unifying mechanism for bacterial cell signalers (4,5-dihydroxy-2,3-pentanedione, lactones and oligopeptides): electron transfer and reactive oxygen species. Practical medical features,” Medical Hypotheses, vol. 69, no. 5, pp. 1105–1110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. C. M. Liou, S. C. Tsai, C. H. Kuo, H. Ting, and S. D. Lee, “Cardiac Fas-dependent and mitochondria-dependent apoptosis after chronic cocaine abuse,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 5988–6001, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. B. J. Borkowski, Y. Cheema, A. U. Shahbaz, S. K. Bhattacharya, and K. T. Weber, “Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited,” European Heart Journal, vol. 32, no. 15, pp. 1846–1853, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. D. M. Bers, “Cardiac excitation-contraction coupling,” Nature, vol. 415, no. 6868, pp. 198–205, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. J. J. Lemasters, T. Qian, C. A. Bradham et al., “Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death,” Journal of Bioenergetics and Biomembranes, vol. 31, no. 4, pp. 305–319, 1999. View at Publisher · View at Google Scholar · View at Scopus
  81. M. U. Khan, Y. Cheema, A. U. Shahbaz et al., “Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states,” Pflügers Archiv, vol. 464, no. 1, pp. 123–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. A. I. Tarasov, E. J. Griffiths, and G. A. Rutter, “Regulation of ATP production by mitochondrial Ca(2+),” Cell Calcium, vol. 52, no. 1, pp. 28–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Cunha-Oliveira, L. Silva, A. M. Silva, A. J. Moreno, C. R. Oliveira, and M. S. Santos, “Mitochondrial complex I dysfunction induced by cocaine and cocaine plus morphine in brain and liver mitochondria,” Toxicology Letters, vol. 219, no. 3, pp. 298–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. A. G. Fantel, C. V. Barber, M. B. Carda, R. W. Tumbic, and B. Mackler, “Studies of the role of ischemia/reperfusion and superoxide anion radical production in the teratogenicity of cocaine,” Teratology, vol. 46, no. 3, pp. 293–300, 1992. View at Publisher · View at Google Scholar
  85. Q. Chen, A. K. Camara, D. F. Stowe, C. L. Hoppel, and E. J. Lesnefsky, “Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion,” American Journal of Physiology. Cell Physiology, vol. 292, no. 1, pp. C137–C147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. A. Remondino, S. H. Kwon, C. Communal et al., “Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway,” Circulation Research, vol. 92, no. 2, pp. 136–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Xiao, J. He, R. D. Gilbert, and L. Zhang, “Cocaine induces apoptosis in fetal myocardial cells through a mitochondria-dependent pathway,” The Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 1, pp. 8–14, 2000. View at Google Scholar
  88. J. He, Y. Xiao, C. A. Casiano, and L. Zhang, “Role of mitochondrial cytochrome c in cocaine-induced apoptosis in coronary artery endothelial cells,” The Journal of Pharmacology and Experimental Therapeutics, vol. 295, no. 3, pp. 896–903, 2000. View at Google Scholar
  89. M. Alvaro-Bartolome, R. La Harpe, L. F. Callado, J. J. Meana, and J. A. García-Sevilla, “Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats,” Neuroscience, vol. 196, pp. 1–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. A. J. Kowaltowski, N. C. de Souza-Pinto, R. F. Castilho, and A. E. Vercesi, “Mitochondria and reactive oxygen species,” Free Radical Biology & Medicine, vol. 47, no. 4, pp. 333–343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. D. B. Zorov, M. Juhaszova, and S. J. Sollott, “Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release,” Physiological Reviews, vol. 94, no. 3, pp. 909–950, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. D. B. Zorov, M. Juhaszova, and S. J. Sollott, “Mitochondrial ROS-induced ROS release: an update and review,” Biochimica et Biophysica Acta, vol. 1757, no. 5-6, pp. 509–517, 2006. View at Google Scholar
  93. V. M. Costa, F. Carvalho, M. L. Bastos, R. A. Carvalho, M. Carvalho, and F. Remiao, “Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases,” Current Medicinal Chemistry, vol. 18, no. 15, pp. 2272–2314, 2011. View at Publisher · View at Google Scholar
  94. A. Bindoli, M. P. Rigobello, and D. J. Deeble, “Biochemical and toxicological properties of the oxidation products of catecholamines,” Free Radical Biology & Medicine, vol. 13, no. 4, pp. 391–405, 1992. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Bindoli, D. J. Deeble, M. P. Rigobello, and L. Galzigna, “Direct and respiratory chain-mediated redox cycling of adrenochrome,” Biochimica et Biophysica Acta, vol. 1016, no. 3, pp. 349–356, 1990. View at Google Scholar
  96. G. S. Behonick, M. J. Novak, E. W. Nealley, and S. I. Baskin, “Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes),” Journal of Applied Toxicology, vol. 21, Suppl 1, pp. S15–S22, 2001. View at Google Scholar
  97. M. L. Genova, N. M. Abd-Elsalam, M. E. El Sayed et al., “Redox cycling of adrenaline and adrenochrome catalysed by mitochondrial complex I,” Archives of Biochemistry and Biophysics, vol. 447, no. 2, pp. 167–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. G. M. Taam, S. Takeo, A. Ziegelhoffer, P. K. Singal, R. E. Beamish, and N. S. Dhalla, “Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart,” The Canadian Journal of Cardiology, vol. 2, no. 2, pp. 88–93, 1986. View at Google Scholar
  99. N. Kaludercic, J. Mialet-Perez, N. Paolocci, A. Parini, and F. Di Lisa, “Monoamine oxidases as sources of oxidants in the heart,” Journal of Molecular and Cellular Cardiology, vol. 73, pp. 34–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. H. C. Stanton and A. Schwartz, “Effects of a hydrazine monoamine oxidase inhibitor (phenelzine) on isoproterenol-induced myocardiopathies in the rat,” The Journal of Pharmacology and Experimental Therapeutics, vol. 157, no. 3, pp. 649–658, 1967. View at Google Scholar
  101. M. Isabelle, C. Monteil, F. Moritz et al., “Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction,” Cardiovascular Research, vol. 67, no. 4, pp. 699–704, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Isabelle, A. Vergeade, F. Moritz et al., “NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction,” Journal of Molecular and Cellular Cardiology, vol. 42, no. 2, pp. 326–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  103. E. Barth, G. Stämmler, B. Speiser, and J. Schaper, “Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man,” Journal of Molecular and Cellular Cardiology, vol. 24, no. 7, pp. 669–681, 1992. View at Publisher · View at Google Scholar · View at Scopus
  104. S. M. Davidson, “Endothelial mitochondria and heart disease,” Cardiovascular Research, vol. 88, no. 1, pp. 58–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Serpillon, B. C. Floyd, R. S. Gupte et al., “Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 297, no. 1, pp. H153–H162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. R. M. Lebovitz, H. Zhang, H. Vogel et al., “Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9782–9787, 1996. View at Google Scholar
  107. D. N. Granger and P. R. Kvietys, “Reperfusion injury and reactive oxygen species: the evolution of a concept,” Redox Biology, vol. 6, pp. 524–551, 2015. View at Publisher · View at Google Scholar · View at Scopus
  108. J. M. McCord, R. S. Roy, and S. W. Schaffer, “Free radicals and myocardial ischemia. The role of xanthine oxidase,” Advances in Myocardiology, vol. 5, pp. 183–189, 1985. View at Google Scholar
  109. S. Baldus, K. Müllerleile, P. Chumley et al., “Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy,” Free Radical Biology & Medicine, vol. 41, no. 8, pp. 1282–1288, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. J. Frijhoff, P. G. Winyard, N. Zarkovic et al., “Clinical relevance of biomarkers of oxidative stress,” Antioxidants & Redox Signaling, vol. 23, no. 14, pp. 1144–1170, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. WHO, Biomarkers in Risk Assessment: Validity and Validation, WHO, Geneva, Switzerland, 2001.
  112. H. Solhi, A. Malekirad, A. Mohammad Kazemifar, and F. Sharifi, “Oxidative stress and lipid peroxidation in prolonged users of methamphetamine,” Drug Metabolism Letters, vol. 7, no. 2, pp. 79–82, 2014. View at Publisher · View at Google Scholar
  113. J. S. Womersley and J. D. Uys, “S-Glutathionylation and redox protein signaling in drug addiction,” Progress in Molecular Biology and Translational Science, vol. 137, pp. 87–121, 2016. View at Publisher · View at Google Scholar · View at Scopus
  114. J. A. Hernandez, R. C. Lopez-Sanchez, and A. Rendon-Ramirez, “Lipids and oxidative stress associated with ethanol-induced neurological damage,” Oxidative Medicine and Cellular Longevity, vol. 2016, p. 1543809, 2016. View at Publisher · View at Google Scholar · View at Scopus
  115. T. A. Zima, L. Fialová, O. Mestek et al., “Oxidative stress, metabolism of ethanol and alcohol-related diseases,” Journal of Biomedical Science, vol. 8, no. 1, pp. 59–70, 2001. View at Publisher · View at Google Scholar
  116. M. C. Huang, C. H. Chen, F. C. Peng, S. H. Tang, and C. C. Chen, “Alterations in oxidative stress status during early alcohol withdrawal in alcoholic patients,” Journal of the Formosan Medical Association, vol. 108, no. 7, pp. 560–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. A. O. Sordi, F. Pechansky, F. H. Kessler et al., “Oxidative stress and BDNF as possible markers for the severity of crack cocaine use in early withdrawal,” Psychopharmacology, vol. 231, no. 20, pp. 4031–4039, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. D. Del Rio, A. J. Stewart, and N. Pellegrini, “A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 15, no. 4, pp. 316–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  119. E. Niki, “Lipid peroxidation products as oxidative stress biomarkers,” BioFactors, vol. 34, no. 2, pp. 171–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. L. Pomierny-Chamioło, A. Moniczewski, K. Wydra, A. Suder, and M. Filip, “Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine,” Neurotoxicity Research, vol. 23, no. 1, pp. 92–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. V. Fineschi, G. Baroldi, F. Centini et al., “Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model,” International Journal of Legal Medicine, vol. 114, no. 6, pp. 323–330, 2001. View at Publisher · View at Google Scholar · View at Scopus
  122. F. Moritz, C. Monteil, M. Isabelle et al., “Role of reactive oxygen species in cocaine-induced cardiac dysfunction,” Cardiovascular Research, vol. 59, no. 4, pp. 834–843, 2003. View at Publisher · View at Google Scholar · View at Scopus
  123. J. Walker, T. Winhusen, J. M. Storkson et al., “Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study,” Human Psychopharmacology, vol. 29, no. 6, pp. 537–543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  124. F. Freitas, N. Brucker, J. Durgante et al., “Urinary 1-hydroxypyrene is associated with oxidative stress and inflammatory biomarkers in acute myocardial infarction,” International Journal of Environmental Research and Public Health, vol. 11, no. 9, pp. 9024–9037, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. I. L. Megson, S. J. Haw, D. E. Newby, and J. P. Pell, “Association between exposure to environmental tobacco smoke and biomarkers of oxidative stress among patients hospitalised with acute myocardial infarction,” PLoS One, vol. 8, no. 12, article e81209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. C. C. de Farias, M. Maes, K. L. Bonifácio et al., “Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: disease and staging biomarkers and new drug targets,” Neuroscience Letters, vol. 617, pp. 66–71, 2016. View at Publisher · View at Google Scholar · View at Scopus
  127. M. Schrag, C. Mueller, M. Zabel et al., “Oxidative stress in blood in Alzheimer’s disease and mild cognitive impairment: a meta-analysis,” Neurobiology of Disease, vol. 59, pp. 100–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. J. C. Narvaez, P. V. Magalhães, G. R. Fries et al., “Peripheral toxicity in crack cocaine use disorders,” Neuroscience Letters, vol. 544, pp. 80–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. J. C. Narvaez, P. V. Magalhães, G. R. Fries et al., “Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex,” The European Journal of Neuroscience, vol. 26, no. 10, pp. 2756–2763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  130. X. Y. Zhang, D. C. Chen, Y. L. Tan et al., “The interplay between BDNF and oxidative stress in chronic schizophrenia,” Psychoneuroendocrinology, vol. 51, pp. 201–208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  131. R. Pacifici, A. I. Fiaschi, L. Micheli et al., “Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat,” International Immunopharmacology, vol. 3, no. 4, pp. 581–592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. C. He, P. C. Hart, D. Germain, and M. G. Bonini, “SOD2 and the mitochondrial UPR: partners regulating cellular phenotypic transitions,” Trends in Biochemical Sciences, vol. 41, no. 7, pp. 568–577, 2016. View at Publisher · View at Google Scholar · View at Scopus
  133. I. N. Zelko, T. J. Mariani, and R. J. Folz, “Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression,” Free Radical Biology & Medicine, vol. 33, no. 3, pp. 337–349, 2002. View at Publisher · View at Google Scholar · View at Scopus
  134. A. Y. Andreyev, Y. E. Kushnareva, and A. A. Starkov, “Mitochondrial metabolism of reactive oxygen species,” Biochemistry (Mosc), vol. 70, no. 2, pp. 200–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Che, R. Wang, X. Li, H. Y. Wang, and X. S. Zheng, “Expanding roles of superoxide dismutases in cell regulation and cancer,” Drug Discovery Today, vol. 21, no. 1, pp. 143–149, 2016. View at Publisher · View at Google Scholar · View at Scopus
  136. S. L. Marklund, “Extracellular superoxide dismutase in human tissues and human cell lines,” The Journal of Clinical Investigation, vol. 74, no. 4, pp. 1398–1403, 1984. View at Publisher · View at Google Scholar
  137. A. Okado-Matsumoto and I. Fridovich, “Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria,” The Journal of Biological Chemistry, vol. 276, no. 42, pp. 38388–38393, 2001. View at Publisher · View at Google Scholar · View at Scopus
  138. R. López-Pedrajas, D. T. Ramírez-Lamelas, B. Muriach et al., “Cocaine promotes oxidative stress and microglial-macrophage activation in rat cerebellum,” Frontiers in Cellular Neuroscience, vol. 9, p. 279, 2015. View at Publisher · View at Google Scholar · View at Scopus
  139. J. D. Uys, L. Knackstedt, P. Hurt et al., “Cocaine-induced adaptations in cellular redox balance contributes to enduring behavioral plasticity,” Neuropsychopharmacology, vol. 36, no. 12, pp. 2551–2560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. P. Ghezzi, “Protein glutathionylation in health and disease,” Biochimica et Biophysica Acta, vol. 1830, no. 5, pp. 3165–3172, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. W. A. Kleinman, D. Komninou, Y. Leutzinger et al., “Protein glutathiolation in human blood,” Biochemical Pharmacology, vol. 65, no. 5, pp. 741–746, 2003. View at Publisher · View at Google Scholar · View at Scopus
  142. H. J. Chen, W. P. Lin, S. D. Chiu, and C. H. Fan, “Multistage mass spectrometric analysis of human hemoglobin glutathionylation: correlation with cigarette smoking,” Chemical Research in Toxicology, vol. 27, no. 5, pp. 864–872, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. J. E. Muscat, W. Kleinman, S. Colosimo et al., “Enhanced protein glutathiolation and oxidative stress in cigarette smokers,” Free Radical Biology & Medicine, vol. 36, no. 4, pp. 464–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  144. O. Firuzi, R. Miri, M. Tavakkoli, and L. Saso, “Antioxidant therapy: current status and future prospects,” Current Medicinal Chemistry, vol. 18, no. 25, pp. 3871–3888, 2011. View at Publisher · View at Google Scholar
  145. L. Saso and O. Firuzi, “Pharmacological applications of antioxidants: lights and shadows,” Current Drug Targets, vol. 15, no. 13, pp. 1177–1199, 2014. View at Publisher · View at Google Scholar
  146. J. D. Gladden, B. R. Zelickson, C. C. Wei et al., “Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload,” Free Radical Biology & Medicine, vol. 51, no. 11, pp. 1975–1984, 2011. View at Publisher · View at Google Scholar · View at Scopus
  147. D. M. Yancey, J. L. Guichard, M. I. Ahmed et al., “Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 308, no. 6, pp. H651–H663, 2015. View at Publisher · View at Google Scholar · View at Scopus
  148. R. A. Smith and M. P. Murphy, “Mitochondria-targeted antioxidants as therapies,” Discovery Medicine, vol. 11, no. 57, pp. 106–114, 2011. View at Google Scholar
  149. M. Erb, B. Hoffmann-Enger, H. Deppe et al., “Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I,” PLoS One, vol. 7, no. 4, article e36153, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. A. Mordente, G. E. Martorana, G. Minotti, and B. Giardina, “Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone),” Chemical Research in Toxicology, vol. 11, no. 1, pp. 54–63, 1998. View at Publisher · View at Google Scholar · View at Scopus
  151. V. Giorgio, V. Petronilli, A. Ghelli et al., “The effects of idebenone on mitochondrial bioenergetics,” Biochimica et Biophysica Acta, vol. 1817, no. 2, pp. 363–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  152. A. Sadakierska-Chudy, M. Frankowska, and M. Filip, “Mitoepigenetics and drug addiction,” Pharmacology & Therapeutics, vol. 144, no. 2, pp. 226–233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  153. J. D. Gladden, B. R. Zelickson, J. L. Guichard et al., “Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 305, no. 10, pp. H1440–H1450, 2013. View at Publisher · View at Google Scholar · View at Scopus
  154. N. Engberding, S. Spiekermann, A. Schaefer et al., “Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?” Circulation, vol. 110, no. 15, pp. 2175–2179, 2004. View at Publisher · View at Google Scholar · View at Scopus
  155. T. P. Cappola, D. A. Kass, G. S. Nelson et al., “Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy,” Circulation, vol. 104, no. 20, pp. 2407–2411, 2001. View at Publisher · View at Google Scholar